Back to News
Market Impact: 0.18
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & Biotech
Novavax shares rose in the latest session on above-average trading volume, signaling near-term buying interest. However, the trend in earnings-estimate revisions does not support expectations for sustained upside, creating a cautious outlook for the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
NVAX-0.35
More News
- Oil price falls amid hope of a breakthrough to end Iran war
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Binance seeks to shore up confidence after record $6.3 billion heist
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Why is Apple stock falling afterhours today?